General Archive
-
News releasesCharities pledge to jump start drug development for brain diseases
The Neurodegeneration Medicines Acceleration Programme (Neuro-MAP), led by medical research charity MRC Technology, will see charities and funding bodies identify…
-
News releases
Catherine Kettleborough elected to SLAS Europe Council
Congratulations to Catherine Kettleborough, MRC Technology’s Associate Director of Drug Discovery Biology, who has been elected to the SLAS Europe…
-
News releases
MRC Technology and Proximagen Collaborate to Develop Novel Therapeutics for Inflammatory and Autoimmune Disease
Project will investigate a small molecule solution for Macrophage migration inhibitory factor
-
News releases
Dr. John Stageman Appointed Chair of the Board for MRC Technology
London, UK, 29 September 2014: MRC Technology (MRCT), a UK medical research charity, today announced the appointment of Dr. John…
-
News releases
Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology
MRC Technology is pleased to highlight that today Merck, known as MSD outside the United States and Canada, announced FDA…
-
News releases
MRC Technology Announces Humanization of Anti-Tau Monoclonal Antibody for Alzheimer’s Disease Therapy
Antibody inhibits Tau aggregation involved in the pathology of Alzheimer’s and other neurodegenerative diseases
-
News releases
MRC Technology and AstraZeneca renew collaboration to identify novel targets for discovery research
The collaboration focuses on the identification and selection of novel drug targets with the potential to become potent and selective…
-
News releases
Dementia Consortium wins One Nucleus BioNewsRound Award at ON Helix 2014
The award was given for the announcement of the formation of a £3m Dementia Consortium in collaboration with Alzheimer’s Research…
-
News releases
MRC Technology sells its melanocortin receptors programme to Pfizer Inc
The melanocortin receptors (MCRs) programme includes a set of small molecules and targets for these small molecules came from Mauro…
-
News releases
MRC Technology and Daiichi Sankyo collaborate to identify novel targets for drug discovery
MRC Technology has established a drug discovery collaboration with Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan.…
-
News releases
16 applications received for first Dementia Consortium deadline
The Dementia Consortium has got off to a great start, with 16 applications received for the first review deadline on…
-
News releases
MRC Technology and Chinese Academy of Science extend collaboration to identify new targets for drug discovery
MRC Technology has extended its existing drug discovery collaboration with the Shanghai Institute of Biotechnology and Cell Biology (SIBCB), Chinese…